CW October 2004
Volume 13Issue Number 10 October 2004 ISSN 10593802 Targeted Therapy to Shut Down Tumor Blood FlowA new class of chemical agent in combination with radiotherapy disrupts tumor blood flow efficiently to cause tumor cell death.
Go to Previous Page Go to Next Page Source & Additional Reading Presented by Peter Hoskin of the Mount Vernon Hospital in the UK at the European Society for Therapeutic Radiology and Oncology (ESTRO) meeting in Amsterdam (October 24-28, 2004). Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW October 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
